Public Pharma: building a fairer pharmaceutical future for Europe and beyond
In October 2026, Wemos global health expert Aliénor Devalière attended the second Public Pharma Conference in Frankfurt. The conference offered space to explore alternatives to the profit-driven pharmaceutical model. Discussions highlighted existing initiatives in public pharmaceutical production, showing how medicines and medical technologies can be made more affordable and accessible. Read Alienor's reflections on the conference. Read more